A cikin sanarwar manema labarai na baya-bayan nan, kamfanin Labaran Juul ya bayyana cewa a cikin masu shan taba da suka yi amfani da sigar e-cigare na Juul da kuma wadanda suka kaurace wa shan taba, an sami raguwa daidai da masu amfani da kwayoyin halitta da ke da alaka da sigari.
KAR KA SHAN TABA KO AMFANI DA JUUL: HAKA?
Nazarin da aka gabatar a taron shekara-shekara na Ƙungiyar Bincike akan Nicotine & Taba ya sake tabbatar da yuwuwar vaping kayayyakin a matsayin madadin sigari masu ƙonewa.
A ranar 23 ga Fabrairu a San Francisco, JUUL Labs ya sanar da sakamakon binciken da aka yi na asibiti wanda ya samo daidaitattun raguwa a cikin wasu masu nazarin halittu na gajeren lokaci (BOE) tsakanin manya masu shan taba da suka yi amfani da kayan JUUL kawai da waɗanda suka daina shan taba a cikin kwanaki biyar. Sakamakon wannan binciken mai taken “Canje-canje a cikin Alamar Bayyanar Halittu Haɗe da Canjawa na Kwanaki 5 daga Sigari da aka ƙone zuwa Tsarin Gishiri na Nicotine An gabatar da shi a taron shekara-shekara na Ƙungiyar Bincike kan Nicotine & Taba (SRNT) na Amurka wanda aka gudanar a wannan Asabar a San Francisco, CA.
Wannan bazuwar, buɗaɗɗen lakabin, nazarin ƙungiyar daidaitattun kulawar likita na masu shan sigari na asibiti JUUL Labs ne ya dauki nauyin wannan kuma Celerion, Inc, wani dakin bincike mai zaman kansa ya gudanar. Wannan binciken yayi nazarin fitsari da samfurori na jini daga masu shan taba manya 90 don gano canje-canje a cikin alamun bayyanar cututtuka daga asali. Zaɓuɓɓukan ƙwayoyin halitta na ɗan gajeren lokaci, NNNN, NNAL, 3-HPMA, MHBMA, S-PMA, HMPMA, CEMA, 1-OHP da COHb, sune carcinogens da aka lura a cikin amfani da sigari masu ƙonewa kuma an san su sosai don ba da gudummawa ga
ciwon daji masu alaka da taba.
An ba da batutuwan karatu ba da gangan ba ga ƙungiyoyi shida kuma, na tsawon kwanaki biyar, sun yi amfani da tsarin gishiri na nicotine (SPSN/JUULpods), sun kaurace wa shan taba, ko kuma ci gaba da amfani da alamar da suka saba. 
na sigari. An sanya masu amfani da SPSN zuwa ƙungiyoyi huɗu daban-daban (batutuwa 15 a kowace ƙungiya) kuma sun yi amfani da ɗayan samfuran nicotine guda huɗu na 5% (Taba ta Virginia, Mint, Mango, ko Cream). Mahalarta sun kaurace wa shan taba sa'o'i 12 kafin a fara binciken don samun ma'anar kwatanta da kuma tantance tasirin amfani da SPSN, abstinence ko shan taba sigari a kan masu alamar biomarkers na 'bayyanannu.
Binciken ya gano cewa don samfuran fitsarin marasa nicotine guda takwas, alamun bayyanar cututtuka sun ragu da jimlar 85,3% a cikin ƙungiyar masu kauracewa idan aka kwatanta da raguwar gabaɗaya na 85,0% a cikin rukunin da aka haɗa da amfani da SPSN (p> 0,05). Wannan yana wakiltar raguwar 99,6% na dangi a cikin jimillar adadin fiddawa ga rukunin SPSN. A cikin rukunin sigari, masu nuna alamun halittu iri ɗaya sun ƙaru da jimillar 14,4% daga asali.
« Mun yi matukar farin cikin raba waɗannan sakamakon tare da abokan aikinmu masu bincike a SRNT 2019, waɗanda ke ci gaba da nuna yuwuwar ingantaccen tasirin samfuran vaping.", in ji Kevin Burns, Shugaba na JUUL Labs. " Matsakaicin ragi a cikin waɗannan takamaiman abubuwan da ke da alaƙa da sigari a cikin ƙungiyoyin da suka ƙaurace wa shan taba da waɗanda suka yi amfani da samfuran JUUL suna tallafawa rawar da samfuran vaping za su iya takawa ga masu shan taba. Ko da yake jaraba, nicotine ba shi da alhakin kai tsaye ga cututtukan daji waɗanda ke da alaƙa da shan taba sigari. Maimakon haka, abubuwan da ke cikin haɗari ne ke da laifi. Mafi yawan abin da za mu iya yi don kawar da sigari, mafi girman tasiri ga lafiyar jama'a. Mun himmatu don gudanar da ingantaccen bincike na kimiyya ta hanyar ba da gudummawa ga tattaunawar da ke gudana game da samfuran vaping kuma muna fatan raba sabon bincike tare da al'ummomin kiwon lafiya, kimiyya da lafiyar jama'a.«
